Rare diseases
Investigational molecules
Locations
Back to Bulgaria27 clinical trials in Kirdzhali, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
BulgariaStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments
BulgariaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
BulgariaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
BulgariaEfficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
BulgariaA Phase 3 Study of Enpatoran to Treat Active Cutaneous Lupus in Patients With or Without Systemic Disease
BulgariaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
BulgariaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
BulgariaAssessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder
BulgariaStudy of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants
BulgariaStudy on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants
BulgariaLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on acute myocardial infarction prevention and treatment, alongside studies evaluating new therapies for atrial fibrillation. Research includes novel approaches to stroke prevention and management of cardiac emergencies.
Current studies explore self-administered treatments and comparative effectiveness of new anticoagulants.
Comprehensive research into major depressive disorder and schizophrenia, evaluating both established and novel therapeutic approaches. Studies include long-term safety assessments and treatment of cognitive impairment.
Multiple trials are examining adjunctive therapies and new compounds for treatment-resistant cases.
Advanced research focusing on Alzheimer's Disease Psychosis, investigating new therapeutic options for symptom management and long-term treatment outcomes.
Current studies evaluate both short-term efficacy and extended safety profiles of novel treatments.
Targeted research on hypertriglyceridemia, including both severe and moderate forms. Studies focus on innovative treatments for lipid management.
Studies examine long-term effectiveness and safety of new therapeutic approaches.
Specialized studies investigating treatments for Systemic Lupus Erythematosus and axial spondyloarthritis, focusing on disease activity reduction and symptom management.
Research emphasizes novel biological therapies and their impact on disease progression.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
